Yan Jin, MingYao Meng, YaFang Zhang, Lin Mo, Hui Gao, YuHong Liu, Jun Wu, PingFen Yang, ZhongZi Zhang, Fu Jia, YiYi Zhao, Ying Huang
BACKGROUND: Diabetic foot ulcer (DFU) is a common and serious complication of diabetes, and its treatment is challenging. Platelet-rich plasma (PRP) gel and umbilical cord mesenchymal stem cells (UC-MSCs) gel have been concerned as new therapies for DFU in recent years, and comparative studies on the efficacy and mechanisms of these methods, however, are rarely reported. METHODS: Thirty patients with DFU were selected and divided into the PRP group and the UC-MSCs group, and wound healing, foot blood vessels (ABI index), infection index (CRP), neuropathy symptoms (TCSS score), and foot skin temperature before and after treatment were compared between the two groups...
January 2024: Skin Research and Technology